UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interpreting plasma estrogen levels in breast cancer: caution needed

Journal of clinical oncology, 2014-05, Vol.32 (14), p.1396-1400

2014

Volltextzugriff (PDF)

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Volltextzugriff (PDF)

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1580-1583

2016

Volltextzugriff (PDF)

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2444-2447

2006

Volltextzugriff (PDF)

Repeated Observation of Breast Tumor Subtypes in Independent Gene Expression Data Sets

Proceedings of the National Academy of Sciences - PNAS, 2003-07, Vol.100 (14), p.8418-8423

2003

Volltextzugriff (PDF)

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5126-5137

2005

Volltextzugriff (PDF)

Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4859-4861

Lønning, Per E

2008

Volltextzugriff (PDF)

Endocrine effects of aromatase inhibitors

Journal of clinical oncology, 2010-02, Vol.28 (6), p.e101-e102

2010

Volltextzugriff (PDF)

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Clinical cancer research, 2022-11, Vol.28 (21), p.4714-4723

2022

Volltextzugriff (PDF)

Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

Clinical cancer research, 2008-10, Vol.14 (19), p.6330-6335

2008

Volltextzugriff (PDF)

Intratumoral Estrogen Disposition in Breast Cancer

Clinical cancer research, 2010-03, Vol.16 (6), p.1790-1801

2010

Volltextzugriff (PDF)

Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation

Clinical cancer research, 2011-08, Vol.17 (15), p.4948-4958

2011

Volltextzugriff (PDF)

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

The New England journal of medicine, 2004-03, Vol.350 (11), p.1081-1092

2004

Volltextzugriff (PDF)

Long-Term Follow-Up of the Intergroup Exemestane Study

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2507-2514

2017

Volltextzugriff (PDF)

Microarray Analysis Reveals a Major Direct Role of DNA Copy Number Alteration in the Transcriptional Program of Human Breast Tumors

Proceedings of the National Academy of Sciences - PNAS, 2002-10, Vol.99 (20), p.12963-12968

2002

Volltextzugriff (PDF)

Exemestane for Breast Cancer Prevention: A Feasible Strategy?

Clinical cancer research, 2005-01, Vol.11 (2), p.918s-924s

Per E. Lønning

2005

Volltextzugriff (PDF)

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Clinical cancer research, 2009-06, Vol.15 (12), p.4165-4173

2009

Volltextzugriff (PDF)

The Potential for Aromatase Inhibition in Breast Cancer Prevention

Clinical cancer research, 2001-12, Vol.7 (12), p.4423s

2001

Volltextzugriff (PDF)

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement

Clinical cancer research, 2005-01, Vol.11 (2 Pt 2), p.861s-864s

2005

Volltextzugriff (PDF)

Influence of Aromatase Inhibitors on Plasma Total Homocysteine in Postmenopausal Breast Cancer Patients

Clinical chemistry (Baltimore, Md.), 1999-02, Vol.45 (2), p.252-256

1999

Volltextzugriff (PDF)

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Clinical cancer research, 2005-01, Vol.11 (2), p.878s-883s

2005

Volltextzugriff (PDF)

Genome sequencing for personalized cancer treatment

Tidsskrift for den Norske Lægeforening, 2012-11, Vol.132 (21), p.2406-2408

2012

Volltextzugriff (PDF)

Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact

Journal of clinical oncology, 2002-07, Vol.20 (13), p.3039-3040

2002

Volltextzugriff (PDF)

Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients

Clinical cancer research, 1996-09, Vol.2 (9), p.1515-1521

1996

Volltextzugriff (PDF)

Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients

Clinical cancer research, 1998-09, Vol.4 (9), p.2125-2128

1998

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionEZB Electronic Journals Library

KollektionPublisher or Other Site

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(47)

Sprache

Englisch
(46)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interpreting plasma estrogen levels in breast cancer: caution needed

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Repeated Observation of Breast Tumor Subtypes in Independent Gene Expression Data Sets

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?

Endocrine effects of aromatase inhibitors

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

Intratumoral Estrogen Disposition in Breast Cancer

Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Long-Term Follow-Up of the Intergroup Exemestane Study

Microarray Analysis Reveals a Major Direct Role of DNA Copy Number Alteration in the Transcriptional Program of Human Breast Tumors

Exemestane for Breast Cancer Prevention: A Feasible Strategy?

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

The Potential for Aromatase Inhibition in Breast Cancer Prevention

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement

Influence of Aromatase Inhibitors on Plasma Total Homocysteine in Postmenopausal Breast Cancer Patients

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Genome sequencing for personalized cancer treatment

Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact

Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients

Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients

Aktive Filter

Suchergebnisse filtern